| Lightcalls.com |
|
|
![]() |
To the untrained inspection a walk...To the untrained inspection a walk-in medical clinic is a convenient portal to health care services. still while safe for patients, walk-in medical clinics set the doctors who work there at risk of catching a financial virus: GST Since GST was introduced, greatest in number health care services have remained GST possessed of immunity This has always been dutiful news for service users, who haven't seen an additional 7% tacked onward to the bill (now 15% in the harmonized provinces of Nova Scotia, recent Brunswick, and Newfoundland and Labrador). However, the freshs has never been as fit for service providers, because unlike farmers (who generally do not charge GST onward their products due to zero-rated status), principally medical practitioners cannot recover the GST they pay. Management companies and the spread of GST Before 1991 many medical practitioners used a "management company" to provide them with space, staff, and equipment. This management company was typically be in possession ofed by a lower-income spouse and/or a family trust and would generally mark up its expenses by 15%) providing a useful income-splitting tool to the medical practitioner. The introduction of GST made management companies a plenteous less useful tool: The amount of non-recoverable GST paid increased because of the management company's mark-up. In addition, GST was added to salaries, insurance, and other previously GST-exempt sumptuousnesss billed to the physician as management rewards This perhaps unintentional "manufacturing" of GST signalled the period of the management company for chiefly medical practitioners. Group practice: incurable GST? Medical clinics are structur in various ways. The clinics may be operated on corporations or partnerships, but it is also habitual for practitioners to set up cost-or fee-sharing arrangements. The GST implications of these "group practices" have been a thorn in the side of the Canadian Medical Association (CMA) and the CCRA since the inception of GST A 1994 paper at the CICAs Commodity Tax Symposium identified medical practices as a critical GST issue. The CMA began working with the CCRA in 1995 to "educate" the dominion on how tax policy should apply to various practice standards The result was the release in 2000 of Policy Statement P-238-Application of the GST/HST to Payments Made Between Parties Within a Medical Practice Organization, which became effective January 1 2001 The locum Policy Statement P-238 provides several examples of when GST might or might not apply in a arrange practice. For example, in a locum arrangement, where a sole-proprietor contracts with another practitioner to provide services to their patients while they're forward vacation or otherwise absent, GST will not apply if the proprietor and locum insert into a bona fide arrangement to share pays earned during that period. forward the other hand, if the payments are structur of the like kind that the proprietor charges the locum for the use of space and equipment, GST will apply to this minister of tangible and real property In stark contrast to the Policy Statement, and greatest in quantity accepted practice, the Tax Court of Canada had occasion in June of 2000 to define the locum arrangement as an employer-employee relationship. This could require the withholding of income tax, CPP and EI, by means of the proprietor and result in the disallowance of expenditures to the locum. The clinic The legal arrangements of clinics are as varied as the physicians who staff them. An effective GST manner of making as set out in the Policy Statement, is for practitioners to share specified universal operating costs, such as crack utilities, and staff, under an agency agreement. single party can make payments by the agency of a common bank account to which each participant contributes, and then be reimbursed by dint of the other participants; or each can pay certain expenditures with a "settling up" at a certain number of agreed-upon point. The CCRA has indicated that where there is an agency relationship among the parties, i.e. the charges are being incurred by united person on behalf of the arrange GST will not apply to the charges between them. However, the conception of "agency" is complex. The CCRA's policy statement onward the subject, which was issued in June of 1995 has still to be approved and is still labelled as a "Draft." Demonstrating that there's an agency relationship could include as it was steps as each doctor preparing a T4 slip for their proportionate share of staff salaries. If the agreement is viewed as a endow of goods and services, GST will apply to the charges. This is the case if a doctor (or professional corporation) operates a clinic and allows other physicians to use the facilities in exchange for a portion of the recompenses they generate. Diagnosis GST Treating a patient requires couple basic steps: diagnosis and treatment. still as the saying goes, "An ounce of prevention is worth a confine in a pound of cure." So how do physicians obstruct GST? They take precautions to avoid spreading it. If the intention is to have a "genuine" cost-sharing agreement, adequate documentation should be prepared in support of this position, and the parties must make certain they follow their agreement. If a physician is entering into an arrangement where they will pay a portion of their unconditional tenures to an existing practice, all parties involved should make strong to structure their arrangements for a like reason as not to inadvertently trigger GST |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |